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Background
We recently conducted a placebo controlled clinical trial
investigating the efficacy of Synvisc
® (hylan G-F 20) for
first metatarsophalangeal joint (MTPJ) osteoarthritis
(OA). The aim of the current study was to devise a clin-
ical prediction rule to identify those people with first
MTPJ OA that are more likely to benefit from intra-
articular injections (of hylan G-F 20 or saline).
Methods
One hundred and fifty one participants with first MTPJ
OA received an intra-articular injection of 1ml hylan G-
F 20 or saline. Potential predictors included intervention
group, demographics, height weight, BMI, symptom
duration and severity, the Foot Health Status Question-
naire (FHSQ), first MTPJ dorsiflexion range of motion
and radiographic OA severity (osteophytes and joint
space narrowing as individual features in either the dor-
sal and lateral view, or as a combination, where scores
of 2 for any feature in any view was considered ‘definite’
OA). The primary measure was a 15-point change in
symptoms scale (range -7- ‘a very great deal worse’ to
+7 –‘ a very great deal better’) at 12-weeks, dichoto-
mised with scores of 3 defined as treatment success.
Predictor variables were initially analysed with univariate
analyses. Significant variables were than entered into a
backward stepwise multivariate logistic regression.
Results
At 12-weeks, 63 (42%) participants reported treatment
success. Predictors of treatment success identified by
univariate analyses were increased FHSQ foot function
(mean difference 7.23, p=0.027), absence of definite
radiographic OA (OR=2.49, p=0.017) and a score of 1
or less for osteophytes on the lateral radiographic view
(OR=2.10, p=0.028). After multivariate logistic regres-
sion analysis, only FHSQ foot function (B=0.02,
p=0.027, OR=1.02) and the absence of definite radio-
graphic OA at the first MTPJ (B=0.906, p=0.017,
OR=2.47) remained significant. The pre-test success rate
of 42% increased to 57% at 12-weeks if the participant
did not exhibit definite radiographic first MTPJ OA
(positive likelihood ratio 1.86 (95% CI 1.11 to 3.13).
Conclusions
This study identified few factors that could predict treat-
ment success of intra-articular injections of hylan G-F
20 or saline for first MTPJ OA. Patients that do not dis-
play definite radiographic first MTPJ OA are more likely
to report success of this treatment.
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